Related Experiment Video

Updated: Apr 13, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K

Review of microRNA in osteosarcoma and chondrosarcoma

Le Chang1, Swati Shrestha, Greg LaChaud

  • 1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave., 13-145 CHS, Los Angeles, CA, 90095, USA.

Medical Oncology (Northwood, London, England)
|April 30, 2015
PubMed

Insights

MicroRNAs (miRNAs) are small noncoding RNAs with potential roles in skeletal sarcomas. miRNA profiling may aid diagnosis, predict chemotherapy resistance, and guide future sarcoma treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
  • Skeletal sarcomas, including osteosarcoma and chondrosarcoma, have complex molecular mechanisms.
  • miRNAs are increasingly recognized for their roles as oncogenes and tumor suppressors in neoplasia.

Purpose of the Study:

  • To review the literature on miRNA expression profiles in skeletal sarcomas.
  • To explore the potential roles of miRNAs in the molecular pathogenesis of these cancers.
  • To discuss the diagnostic, prognostic, and therapeutic implications of miRNAs in skeletal sarcomas.

Main Methods:

  • Literature review of studies investigating miRNA expression in skeletal sarcomas.
  • Analysis of miRNA roles as oncogenes and tumor suppressors.
  • Discussion of current and future clinical applications of miRNA research.

Main Results:

  • Emerging evidence suggests distinct miRNA expression profiles in skeletal sarcomas.
  • miRNAs may serve as biomarkers for diagnosis and prognosis.
  • miRNA dysregulation is implicated in sarcoma development and progression.

Conclusions:

  • miRNA profiling shows promise for clarifying differential diagnoses of skeletal sarcomas.
  • miRNAs could predict patient response to chemotherapy.
  • Targeting miRNAs represents a potential future therapeutic strategy for skeletal sarcomas.

More Related Videos

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

428
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K